Get a free sample of Peanut Allergy Treatment Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Peanut Allergy Treatment Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Peanut Allergy Treatment Market Size
Peanut Allergy Treatment Market size was valued at USD 483.5 million in 2023 and is anticipated to showcase growth at 12.1% CAGR from 2024 to 2032. Growing prevalence of peanut allergies, increasing approvals for immunotherapeutic treatments, and increasing investments for developing new treatment modalities is driving the revenue growth of the global market. Additionally, rising awareness towards timely treatment of peanut allergies is also adding to the revenue growth of the market.
Peanut allergy treatment includes various therapeutic interventions designed to manage and treat allergies. This market includes a range of treatment modalities aimed at reducing allergic reactions and increase tolerance to peanut proteins to improve the quality of life of patients.
How big is the peanut allergy treatment market?
Peanut allergy treatment industry size was worth USD 483.5 million in 2023 and is projected to expand at 12.1% CAGR from 2024 to 2032, due to growing prevalence of peanut allergies, and increasing investments for developing new treatment modalities.
Why is the demand for injectable peanut allergy treatment rising?
The injectable route of administration segment in the peanut allergy treatment industry accounted for 51.4% share in 2023 as they find extensive use in delivering epinephrine and immunotherapeutic treatments such as Dupixent.
Why is the demand for peanut allergy epinephrine drugs rising?
The epinephrine drug class segment in the peanut allergy treatment industry accounted for USD 233 million in 2023 owing to drug ability to reverse any life-threatening symptoms such as swelling of the airway and low blood pressure.
Which factors are driving growth in peanut allergy treatment market in North America?
North America peanut allergy treatment industry accounted for 41.3% share in 2023 and is projected to expand at substantial rate from 2024 to 2032, led by the increasing prevalence of peanut allergies in the region.